Birinci Basamak Hekimliğinde Gebelik Dönemi ve Psikiyatrik Hastalıklar

Weissman,M.,Olfson M.,(1995).Depression in women: implications for healt- hcare research. Science, 269, (799–801)

Engindeniz AN, Küey L, Kültür S. Edinburg Doğum Sonrası Depresyon Ölçeği Türkçe Formu Geçerlilik ve güvenirlik çalışması, Bahar Sempozyumları 1997;1:51-2

Bödecs, T., Horvath, B., Kovacs, L., Diffelne Nemeth, M., Sandor, J., (2009). Prevalence of depres- sion and anxiety in early pregnancy on a population based Hungarian sample. Orv Hetil., 150, (1888-1893)

Çalık, K.Y., Aktaş, S., (2011). Gebelikte Depresyon: Sıklık, Risk Faktörleri Ve Tedavisi, Psikiyatride Güncel Yaklaşımlar, 3(1), (142-162)

Sevindik, F., (2005). Elazığ ilinde gebelikte depresyon prevelansı ve etkileyen faktörler (Yüksek lisans tezi). Elazığ, Fırat Üniversitesi, ss, 26-33

Field T, Hernandez-Reif M, Vera Y, Gil K, Diego M, Bendell D, Yandı R. Anxiety and anger effects on depressed mother-infant spontaneous and imitative interactions. İnfant Behavior and Development 2005;28, 1-9

Aydın N, Güleç M. Gebelik ve Ruh Sağlığı. Yüksel Ş, Gülseren L, Başterzi AD(ed.), Kadınların Yaşamı ve Kadın Ruh Sağlığı 1.baskı, TPD yayınları, Ankara, 2013,261-286

Sutter-Dallay, A. L., Cosnefroy, O., Glatigny-Dallay, E., Verdoux, H., & Rascle, N. (2012). Evolution of perinatal depressive symptoms from pregnancy to two years postpartum in a low-risk sample: The MATQUID cohort. Journal of Affective Disorders, 139(1), 23–29.

Giardinelli, L., Innocenti, A., Benni, L., Stefanini, M. C., Lino, G., Lunardi, C., … Faravelli, C. (2011). Depression and anxiety in perinatal period: prevalence and risk factors in an Italian sample. Archives of Women’s Mental Health, 15(1), 21–30.

Uguz F, Sahingoz M, sonmez E.O, Karsidag C Yüksel G, Annagur BB, Annagur A. The effects of maternal psychological distress on fetal Weight and gestational age: A comparative study. Journal of Psychosomatic Research 2013; http://dx.doi.org/10.1016/j.jpsychores.2013.02.008.

Wogelius, P., Nørgaard, M., Gislum, M., Pedersen, L., Munk, E., Mortensen, P. B., Sørensen, H. T. (2006). Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations. Epidemiology, 17(6), 701–704.

Källén, B., & Otterblad Olausson, P. (2006). Antidepressant drugs during pregnancy and infant congenital heart defect. Reproductive Toxicology, 21(3), 221–222.

Louik, C., Lin, A. E., Werler, M. M., Hernández-Díaz, S., & Mitchell, A. A. (2007). First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects. New England Journal of Medicine, 356(26), 2675–2683

Jimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Jensen, J. K., Afzal, S., … Poulsen, H. E. (2012). Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open, 2(3), e001148

ACOG Practice Bulletin No. 92: Use of Psychiatric Medications During Pregnancy and Lactation. (2008). Obstetrics & Gynecology, 111(4), 1001–1020.

Boden, R., Lundgren, M., Brandt, L., Reutfors, J., Andersen, M., & Kieler, H. (2012). Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ, 345(nov07 6), e7085–e7085. doi:10.1136/bmj.e7085

Viguera, A. C., Whitfield, T., Baldessarini, R. J., Newport, D. J., Stowe, Z., Reminick, A., … Cohen, L. S. (2007). Risk of Recurrence in Women With Bipolar Disorder During Pregnancy: Prospective Study of Mood Stabilizer Discontinuation. American Journal of Psychiatry, 164(12), 1817–1824. doi:10.1176/appi.ajp.2007.06101639

Solari H, Dickson KE, Miller L. Understanding and treating women with schizoprenia during pregnancy and postpartum—Motherick Update 2008. Can J Clin Pharmacol 2009 16:e23-32.

Newport, D. J., Viguera, A. C., Beach, A. J., Ritchie, J. C., Cohen, L. S., & Stowe, Z. N. (2005). Lithium Placental Passage and Obstetrical Outcome: Implications for Clinical Management During Late Pregnancy. American Journal of Psychiatry, 162(11), 2162–2170.

Pinelli, J. M., Symington, A. J., Cunningham, K. A., & Paes, B. A. (2002). Case report and review of the perinatal implications of maternal lithium use. American Journal of Obstetrics and Gynecology, 187(1), 245–249.

Kozma, C. (2005). Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: Another clinical report and a review of the literature. American Journal of Medical Genetics Part A, 132A(4), 441–444.

Jentink, J., Loane, M. A., Dolk, H., Barisic, I., Garne, E., Morris, J. K., & de Jong-van den Berg, L. T. W. (2010). Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations. New England Journal of Medicine, 362(23), 2185–2193.

Vajda, F. J. E., Dodd, S., & Horgan, D. (2013). Lamotrigine in epilepsy, pregnancy and psychiatry – a drug for all seasons? Journal of Clinical Neuroscience, 20(1), 13–16.

Einarson, A., & Boskovic, R. (2009). Use and Safety of Antipsychotic Drugs During Pregnancy. Journal of Psychiatric Practice, 15(3), 183–192.

Diav-Citrin O, Shectman S, Ornoy S, Arnon J, Schaefer C, Garbis H, et al. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. J Clin Psychiatry 2005;66(3):317-22.

Schrire, I. (1963). Trifluoperazine and foetal abnormalities. The Lancet, 281(7273), 174.

Newport, D. J., Calamaras, M. R., DeVane, C. L., Donovan, J., Beach, A. J., Winn, S., … Stowe, Z. N. (2007). Atypical Antipsychotic Administration During Late Pregnancy: Placental Passage and Obstetrical Outcomes. American Journal of Psychiatry, 164(8), 1214–1220.

Gati A, Trixler M, Tenyi T. Pregnancy and atypical antipsychotics. European Neuropsychopharmacology 2001; 11 (Supplement 3):247

Dickson, R. A., & Hogg, L. (1998). Pregnancy of a Patient Treated With Clozapine. Psychiatric Services, 49(8), 1081–1083

Di Michele, V., Ramenghi, L., & Sabatino, G. (1996). Clozapine and lorazepam administration in pregnancy. European Psychiatry, 11(4), 214.

Stoner SC, Sommi RW, Jr., Marken PA, Anya I, Vaughn J. Clozapine ese in two full-term pregnancies. J Clin Psychiatry 1997;58(8):364-5

Mendhekar DN, Sharma JB, Srivastava PK, War L. Clozapine and pregnancy. J Clin Psychiatry 2003;64(7):850

Yaeger, D., Smith, H. G., & Altshuler, L. L. (2006). Atypical Antipsychotics in the Treatment of Schizophrenia During Pregnancy and the Postpartum. American Journal of Psychiatry, 163(12), 2064–2070.

McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, et al. Pregnancy outcome of Women using atypical antipsychotic drugs:a prospective comparetive study. J Clin Psychiatry 2005;66(4):444-9.

Newcomer JW. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 2007;68 Suppl 1:20-7

Identifying and Treating Maternal Depression: Strategies & Considerations for Health Plans. NIHCM. Foundation Issue Brief. June 2010.

Grote, N. K., & Frank, E. (2003). Difficult-to-treat depression: the role of contexts and comorbidities. Biological Psychiatry, 53(8), 660–670.

Leis, J. A., Mendelson, T., Tandon, S. D., & Perry, D. F. (2009). A systematic review of home-based interventions to prevent and treat postpartum depression. Archives of Women’s Mental Health, 12(1), 3–13.

Sweet, M. A., & Appelbaum, M. I. (2004). Is Home Visiting an Effective Strategy? A Meta-Analytic Review of Home Visiting Programs for Families With Young Children. Child Development, 75(5), 1435–1456.

Saatcioglu O, Tomruk NB, Theuse of electroconvulsivetherapy in pregnancy: a review. Isr J PsychiatryRelatSci. 2011;48(1):6-11

Sit, D., Rothschild, A. J., & Wisner, K. L. (2006). A Review of Postpartum Psychosis. Journal of Women’s Health, 15(4), 352–368

Parry, B. L., Meliska, C. J., Sorenson, D. L., Lopez, A. M., Martinez, L. F., Nowakowski, S., Kripke, D. F. (2008). Plasma Melatonin Circadian Rhythm Disturbances During Pregnancy and Postpartum in Depressed Women and Women With Personal or Family Histories of Depression. American Journal of Psychiatry, 165(12), 1551–1558.

Sandström, M., Wiberg, B., Wikman, M., Willman, A.-K., & Högberg, U. (2008). A pilot study of eye movement desensitisation and reprocessing treatment (EMDR) for post-traumatic stress after childbirth. Midwifery, 24(1), 62–73.